Analysis of genetic polymorphisms of steroid 5α-reductase type 1 and 2 genes in Korean men with androgenetic alopecia

Journal of Dermatological Science

Volumn 31, Issue 2, 2003, Pages 135-141

  Ha, Seog Jun ^a   Kim, Jung Soo ^a   Myung, Jae Wook ^a   Lee, Hyun Jeong ^a,b   Kim, Jin Wou ^a  

^a The Catholic University of Korea   (South Korea)

^b CNP Cha and Park Hospital   (South Korea)

Author keywords

Androgenetic; Genes; Genetic polymorphisms

Indexed keywords

ALANINE; FINASTERIDE; ISOENZYME; LEUCINE; STEROID 5ALPHA REDUCTASE; THREONINE; VALINE;

ADULT; AGED; ALOPECIA; ARTICLE; CLINICAL STUDY; CODON; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE; GENETIC ANALYSIS; GENETIC POLYMORPHISM; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; MALE TYPE ALOPECIA; MEDICAL ASSESSMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; AGED; ALOPECIA; ASIAN CONTINENTAL ANCESTRY GROUP; ENZYME INHIBITORS; FINASTERIDE; GENOTYPE; HUMANS; KOREA; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; TESTOSTERONE 5-ALPHA-REDUCTASE;

EID: 0037379637     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-1811(02)00145-7     Document Type: Article

References (19)

1. Hamilton J.D. Male hormone stimulation is a prerequisite and an incitant in common baldness. Am. J. Anat. 71:1942;451-480.
2. Imperato-McGinley J., Guerrero L., Gautier T., Peterson R.E. Steroid 5 alpha-reductase deficiency in man: an inherited form of male pseudohermaphroditism. Science. 186:1974;1213-1215.
3. Jenkins E.P., Hsieh C.L., Milatovich A., Normington K., Berman D.M., Francke U., et al. Characterization and chromosomal mapping of a human steroid 5 alpha-reductase gene and pseudogene and mapping of the mouse homologue. Genomics. 11:1991;1102-1112.
4. Thigpen A.E., Silver R.I., Guileyardo J.M., Casey M.L., McConnell J.D., Russell D.W. Tissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expression. J. Clin. Invest. 92:1993;903-910.
5. Dallob A.L., Sadick N.S., Unger W., Lipert S., Geissler L.A., Gregoire S.L., et al. The effect of finasteride, a 5 alpha-reductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldness. J. Clin. Endocrinol. Metab. 79:1994;703-706.
6. Marks R. Can male-pattern baldness be prevented. Lancet. 350:1997;36.
7. Ellis J.A., Stebbing M., Harrap S.B. Genetic analysis of male pattern baldness and the 5 alpha-reductase genes. J. Invest. Dermatol. 110:1998;849-853.
8. Makridakis N.M., di Salle E., Reichardt J.K. Biochemical and pharmacogenetic dissection of human steroid 5 alpha-reductase type II. Pharmacogenetics. 10:2000;407-413.
9. Dawber R. Diseases of the hair and scalp. 1997;67-122 Blackwell Science, Oxford.
10. Norwood O.T. Male pattern baldness: classification and incidence. South Med. J. 68:1975;1359-1365.
11. Ludwig E. Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex. Br. J. Dermatol. 97:1977;247-254.
12. Morissette J., Durocher F., Leblanc J.F., Normand T., Labrie F., Simard J. Genetic linkage mapping of the human steroid 5 alpha-reductase type 2 gene (SRD5A2) close to D2S352 on chromosome region 2p23-p22. Cytogenet. Cell Genet. 73:1996;304-307.
13. Makridakis N., Ross R.K., Pike M.C., Chang L., Stanczyk F.Z., Kolonel L.N., et al. A prevalent missense substitution that modulates activity of prostatic steroid 5 alpha-reductase. Cancer Res. 57:1997;1020-1022.
14. Jaffe J.M., Malkowicz S.B., Walker A.H., MacBride S., Peschel R., Tomaszewski J., et al. Association of SRD5A2 genotype and pathological characteristics of prostate tumors. Cancer Res. 60:2000;1626-1630.
15. Kuster W., Happle R. The inheritance of common baldness: two B or not two B? J. Am. Acad. Dermatol. 11:1984;921-926.
16. Makridakis N.M., Ross R.K., Pike M.C., Crocitto L.E., Kolonel L.N., Pearce C.L., et al. Association of mis-sense substitution in SRD5A2 gene with prostate cancer in African-American and Hispanic men in Los Angeles, USA. Lancet. 354:1999;975-978.
17. Febbo P.G., Kantoff P.W., Platz E.A., Casey D., Batter S., Giovannucci E., et al. The V89L polymorphism in the 5 alpha-reductase type 2 gene and risk of prostate cancer. Cancer Res. 59:1999;5878-5881.
18. Vilchis F., Hernandez D., Canto P., Mendez J.P., Chavez B. Codon 89 polymorphism of the human 5 alpha-steroid reductase type 2 gene. Clin. Genet. 51:1997;399-402.
19. Ellis J.A., Stebbing M., Harrap S.B. Polymorphism of androgen receptor gene is associated with male pattern baldness. J. Invest. Dermatol. 116:2001;452-455.